Australia's Medical Developments International gains on quarterly revenue growth
** Shares of Medical Developments International MVP.AX rise as much as 12% to A$0.700, its biggest intraday gain since August 5 ** The pharmaceuticals company says group revenue for Q1 FY26 was A$10.9 million ($7.14 million), up A$1.9 million on pcp ** Stock hits highest level since October 2 ** MVP currently up 10.4%, bringing YTD gains to 54.3% ($1 = 1.5260 Australian dollars) (Reporting by Adwitiya Srivastava in Bengaluru) ((Adwitiya.Srivastava@thomsonreuters.com))
Recent news on Medical Developments International
See all newsMedical Developments International soars on robust quarterly revenue
Brief: Medical Developments International Posts Qtrly Group Revenue A$10.5 Million
Brief: Vaxxas Appoints Former Merck Global Vaccines President David Peacock As CEO
Brief: Medical Developments International Posts Group Revenue For Q1FY26 At A$10.9 MLN
Australia's Medical Developments International gains on quarterly revenue growth